We report for the first time a potential reciprocal regulatory relationship between PEDF and p-NFκB-p65, which may be a key mechanism driving differential PEDF expression and anti-metastatic function in pre-menopausal TNBC and post-menopausal ER+/HER2- BC. The gene discussed is ERBB2; the disease is breast cancer.